What is MBX Biosciences, Inc.'s shares (basic)?

MBX Biosciences, Inc. (MBX) reported shares (basic) of 46.6M in Q1 2026.

How has MBX Biosciences, Inc.'s shares (basic) changed year-over-year?

MBX Biosciences, Inc.'s shares (basic) increased by 39.4% year-over-year, from 33.4M to 46.6M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

MBX Biosciences, Inc. MBX Shares (Basic)

Shares (Basic) at other companies

Eli LillyLLY

894.5M-0.5%

AmgenAMGN

540M+0.4%

Viking TherapeuticsVKTX

115.6M+3.1%

Amylyx Pharmaceuticals, Inc.AMLX

110.6M+29.0%

BridgeBio PharmaBBIO

194.8M+2.4%

Nurix Therapeutics, Inc.NRIX

110.1M+31.7%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.3B+475%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s shares (basic)?: MBX Biosciences, Inc. (MBX) reported shares (basic) of 46.6M in Q1 2026.
How has MBX Biosciences, Inc.'s shares (basic) changed year-over-year?: MBX Biosciences, Inc.'s shares (basic) increased by 39.4% year-over-year, from 33.4M to 46.6M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.